DIA
Drug Information Association Logo
« Back to Listing

SAS/JMP Innovation Theater: Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP Clinical

Track:
Innovation Theater

Day & Time:
June 18, 11:45AM - 12:15PM (Pacific Standard Time)

Session Number:
351

Room Number:
Exhibit Hall

Level:
Intermediate

Type:
Special Session

Title:
SAS/JMP Innovation Theater: Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP Clinical

Chair(s):
SAS Institute Inc., JMP Division
JMP, A Business Unit of SAS, United States

Description:
International guidelines suggest that clinical trial data should be actively monitored to ensure data quality. Traditional on-site review is time consuming, expensive, and as is true for any manual effort, limited in scope and prone to error. In contrast, risk-based monitoring (RBM) employs centralized review of trial data to determine if sites should receive more extensive review. We demonstrate the RBM and fraud detection capabilities of JMP Clinical to assess clinical trial data quality.